EMD534085

Catalog No. :
ACVRSM322
CAS No. :
858668-07-2
Molecular Formula :
C25H31F3N4O2
Molecular Weight :
476.54

IUPAC Name:1-(2-(dimethylamino)ethyl)-3-(((2R,4aS,5R,10bS)-5-phenyl-9-(trifluoromethyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinolin-2-yl)methyl)urea

EMD534085 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg99%$308.00Login to see priceInquiryInquiry
5mg99%$676.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEMD534085
IUPAC Name1-(2-(dimethylamino)ethyl)-3-(((2R,4aS,5R,10bS)-5-phenyl-9-(trifluoromethyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinolin-2-yl)methyl)urea
Molecular FormulaC25H31F3N4O2
Molecular Weight476.54
SMILESO=C(NC[C@H]1CC[C@@]2([H])[C@H](C3=CC=CC=C3)NC4=C(C=C(C(F)(F)F)C=C4)[C@@]2([H])O1)NCCN(C)C
InChI KeyMARIUIDCPUZLKZ-FUKQBSRTSA-N
SynonymNSC763564 | NSC-763564 | Q27273980 | EMD 534085 | EX-A2369 | BCP9000643 | BDBM50313428 | BCP0726000144 | EMD534085 | EMD-534085 | 1-(2-(dimethylamino)ethyl)-3-(((2R,4aS,5R,10bS)-5-phenyl-9-(trifluoromethyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoli
CAS No.858668-07-2
PubChem CID23634407

Synthetic Route by SureRoute

1. ACVRSM322 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRNLM874 route compound structure diagram
    ACRNLM8741245570-04-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACVRSM322 route product structure diagram
    ACVRSM322858668-07-2
Inquiry

2. ACVRSM322 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRNLM874 route compound structure diagram
    ACRNLM8741245570-04-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVRSM322 route product structure diagram
    ACVRSM322858668-07-2
Inquiry

Comments (0)